Print Page  Close Window

Investor Relations
Corporate Profile

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Allscripts is one of the largest public companies focused exclusively on healthcare information technology globally.  Allscripts offers healthcare providers, payers and life sciences companies globally a complete portfolio of clinical, financial, population health management, transaction and managed IT services and other solutions.  As of December 31, 2015, we had approximately 6,900 employees worldwide.   For 2015, revenue was $1.4 billion.  We operate in 12 countries including Australia, Canada, India Israel and the United Kingdom.

Our industry leading client base of 180,000 physicians across approximately 45,000 ambulatory facilities, 2,500 hospitals and 17,000 post-acute organizations.

We invite investors to learn more about Allscripts and the impact we have on health care around the globe - To learn more, visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.  Or please contact Seth R. Frank, Vice President of Investor Relations at

Recent NewsRSS Feeds | More >>
12/08/16Los Angeles County selects EZ-CAP to afford greater care access across the community
EZ-CAP suite efficiently and cost effectively automates complex healthcare administration CHICAGO, Dec. 08, 2016 (GLOBE NEWSWIRE) -- The Los Angeles County Department of Health Services has selected the Allscripts (NASDAQ:MDRX) managed care solution EZ-CAP to more effectively operate its current managed care portfolio and over 336,000 managed care patients. This partnership will empower Los Angeles County to realize numerous benefits in cost savings, improve effectiveness, and operational eff... 
Printer Friendly Version
12/05/16Allscripts to extend EMR offerings in Australia
MELBOURNE, Australia, Dec. 04, 2016 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) announced today its acquisition of Core Medical Solutions, a recognised healthcare IT software leader with a strong presence in both Victoria and Western Australia. This acquisition significantly increases Allscripts global offerings, and builds upon its commitment to delivering the most advanced solutions in Australia, which support proactive care management for clinicians and consumers of care alike. Allscripts ... 
Printer Friendly Version
11/29/162bPrecise, an Allscripts company, partners with Holston Medical Group to launch early adopter genomics and precision medicine initiative
Multi-specialty providers to use 2bPrecise clinical-genomic solution to improve patient care in areas of behavioral health CHICAGO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- 2bPrecise LLC, a wholly owned subsidiary of Allscripts Healthcare Inc. (Allscripts) (NASDAQ:MDRX), will deploy its cloud-based genomics and precision medicine solution at Holston Medical Group (HMG). HMG is one of the largest multi-specialty providers in the Southeastern United States, and a national leader in clinical research a... 
Printer Friendly Version
11/17/16Allscripts Announces Expanded Share Repurchase Program
CHICAGO, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ:MDRX) announced today that its Board of Directors has approved a new stock repurchase program under which Allscripts may purchase up to $200 million of its common stock through December 31, 2019. The new stock repurchase program supersedes the previously existing stock repurchase program, which authorized Allscripts to repurchase $150 million of its common stock through December 31, 2018. Under the prior prog... 
Printer Friendly Version
EventsMore >>
11/03/16 4:30 p.m. ET
Q3 2016 Allscripts Healthcare Solutions, Inc. Earnings Conference Call
7th Annual J.P. Morgan U.S. All Stars Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources